Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Growing prevalence of oncologic cases, constant technological advancements in diagnostics, and increasing demand for effective screening tests are some of the prime factors spurring demand for screening tools and techniques across the world. Rising awareness and supportive government initiatives are some additional factors anticipated to boost market growth during the forecast period.
This report offers an overview of the market trends, drivers, and barriers with respect to the USA Lung Cancer Diagnostic Tests market. It also provides a detailed overview of the market of different regions across West USA, South USA, Middle West USA, Northeast USA. The report deeply analyzes type and application in the USA Lung Cancer Diagnostic Tests market. Detailed analysis of key players, along with key growth strategies adopted by Lung Cancer Diagnostic Tests industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.
By Player:
Epigenomics AG
BioMarker Strategies
Quest Diagnostics
Mayo Clinic
AIT
HalioDx
Emory Healthcare
Biodesix
Courtagen Life Sciences Inc
GlycoZym
Agilent
By Type:
Immunoassays
Flow Cytometry
Rapid Tests
Molecular Assays
Tissue Arrays
Circulating Tumor Cells
Pharmacodiagnostics
Biomarkers
Other Diagnostics Methods
By End-User:
Precision Medicine
Personalized Medicine
Cancer Monitoring
By Region:
-
West USA
-
South USA
-
Middle West USA
-
Northeast USA
TABLE OF CONTENT
1 Report Overview
-
1.1 Product Definition and Scope
-
1.2 PEST (Political, Economic, Social and Technological) Analysis of Lung Cancer Diagnostic Tests Market
-
1.3 Market Segment by Type
-
1.3.1 USA Lung Cancer Diagnostic Tests Market Size and Growth Rate of Immunoassays from 2016 to 2027
-
1.3.2 USA Lung Cancer Diagnostic Tests Market Size and Growth Rate of Flow Cytometry from 2016 to 2027
-
1.3.3 USA Lung Cancer Diagnostic Tests Market Size and Growth Rate of Rapid Tests from 2016 to 2027
-
1.3.4 USA Lung Cancer Diagnostic Tests Market Size and Growth Rate of Molecular Assays from 2016 to 2027
-
1.3.5 USA Lung Cancer Diagnostic Tests Market Size and Growth Rate of Tissue Arrays from 2016 to 2027
-
1.3.6 USA Lung Cancer Diagnostic Tests Market Size and Growth Rate of Circulating Tumor Cells from 2016 to 2027
-
1.3.7 USA Lung Cancer Diagnostic Tests Market Size and Growth Rate of Pharmacodiagnostics from 2016 to 2027
-
1.3.8 USA Lung Cancer Diagnostic Tests Market Size and Growth Rate of Biomarkers from 2016 to 2027
-
1.3.9 USA Lung Cancer Diagnostic Tests Market Size and Growth Rate of Other Diagnostics Methods from 2016 to 2027
-
1.4 Market Segment by Application
-
1.4.1 USA Lung Cancer Diagnostic Tests Market Size and Growth Rate of Precision Medicine from 2016 to 2027
-
1.4.2 USA Lung Cancer Diagnostic Tests Market Size and Growth Rate of Personalized Medicine from 2016 to 2027
-
1.4.3 USA Lung Cancer Diagnostic Tests Market Size and Growth Rate of Cancer Monitoring from 2016 to 2027
-
1.5 Market Segment by Regions
-
1.5.1 West USA Lung Cancer Diagnostic Tests Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.2 South USA Lung Cancer Diagnostic Tests Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.3 Middle West USA Lung Cancer Diagnostic Tests Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.4 Northeast USA Lung Cancer Diagnostic Tests Consumption Market Size and Growth Rate from 2016 to 2027
2 Market Trends and Competitive Landscape
-
2.1 Market Trends and Dynamics
-
2.1.1 Market Challenges and Restraints
-
2.1.2 Market Opportunities and Potentials
-
2.1.3 Mergers and Acquisitions
-
2.2 Competitive Landscape Analysis
-
2.2.1 Industrial Concentration Analysis
-
2.2.2 Porter's Five Forces Analysis of the Industry
-
2.2.3 SWOT Analysis for New Entrants
-
2.3 Coronavirus (COVID-19) Distribution and its Impact on the Industry
3 Segmentation of Lung Cancer Diagnostic Tests Market by Types
-
3.1 Products Development Trends of Different Types
-
3.2 Products Types of Major Vendors
-
3.3 Competitive Landscape Analysis of Different Types
-
3.4 Market Size of Lung Cancer Diagnostic Tests by Major Types
-
3.4.1 Market Size and Growth Rate of Immunoassays
-
3.4.2 Market Size and Growth Rate of Flow Cytometry
-
3.4.3 Market Size and Growth Rate of Rapid Tests
-
3.4.4 Market Size and Growth Rate of Molecular Assays
-
3.4.5 Market Size and Growth Rate of Tissue Arrays
-
3.4.6 Market Size and Growth Rate of Circulating Tumor Cells
-
3.4.7 Market Size and Growth Rate of Pharmacodiagnostics
-
3.4.8 Market Size and Growth Rate of Biomarkers
-
3.4.9 Market Size and Growth Rate of Other Diagnostics Methods
4 Segmentation of Lung Cancer Diagnostic Tests Market by End-Users
-
4.1 Downstream Client Analysis by End-Users
-
4.2 Competitive Landscape Analysis of Different End-Users
-
4.3 Market Potential Analysis of Different End-Users
-
4.4 Market Size of Lung Cancer Diagnostic Tests by Major End-Users
-
4.4.1 Market Size and Growth Rate of Lung Cancer Diagnostic Tests in Precision Medicine
-
4.4.2 Market Size and Growth Rate of Lung Cancer Diagnostic Tests in Personalized Medicine
-
4.4.3 Market Size and Growth Rate of Lung Cancer Diagnostic Tests in Cancer Monitoring
5 Market Analysis by Regions
-
5.1 USA Lung Cancer Diagnostic Tests Production Analysis by Regions
-
5.2 USA Lung Cancer Diagnostic Tests Consumption Analysis by Regions
-
5.3 Coronavirus (COVID-19) Impact on USA Economy
6 West USA Lung Cancer Diagnostic Tests Landscape Analysis
-
6.1 West USA Lung Cancer Diagnostic Tests Landscape Analysis by Major Types
-
6.2 West USA Lung Cancer Diagnostic Tests Landscape Analysis by Major End-Users
7 South USA Lung Cancer Diagnostic Tests Landscape Analysis
-
7.1 South USA Lung Cancer Diagnostic Tests Landscape Analysis by Major Types
-
7.2 South USA Lung Cancer Diagnostic Tests Landscape Analysis by Major End-Users
8 Middle West USA Lung Cancer Diagnostic Tests Landscape Analysis
-
8.1 Middle West USA Lung Cancer Diagnostic Tests Landscape Analysis by Major Types
-
8.2 Middle West USA Lung Cancer Diagnostic Tests Landscape Analysis by Major End-Users
9 Northeast USA Lung Cancer Diagnostic Tests Landscape Analysis
-
9.1 Northeast USA Lung Cancer Diagnostic Tests Landscape Analysis by Major Types
-
9.2 Northeast USA Lung Cancer Diagnostic Tests Landscape Analysis by Major End-Users
10 Major Players Profiles
-
10.1 Epigenomics AG
-
10.1.1 Epigenomics AG Company Profile and Recent Development
-
10.1.2 Market Performance
-
10.1.3 Product and Service Introduction
-
10.2 BioMarker Strategies
-
10.2.1 BioMarker Strategies Company Profile and Recent Development
-
10.2.2 Market Performance
-
10.2.3 Product and Service Introduction
-
10.3 Quest Diagnostics
-
10.3.1 Quest Diagnostics Company Profile and Recent Development
-
10.3.2 Market Performance
-
10.3.3 Product and Service Introduction
-
10.4 Mayo Clinic
-
10.4.1 Mayo Clinic Company Profile and Recent Development
-
10.4.2 Market Performance
-
10.4.3 Product and Service Introduction
-
10.5 AIT
-
10.5.1 AIT Company Profile and Recent Development
-
10.5.2 Market Performance
-
10.5.3 Product and Service Introduction
-
10.6 HalioDx
-
10.6.1 HalioDx Company Profile and Recent Development
-
10.6.2 Market Performance
-
10.6.3 Product and Service Introduction
-
10.7 Emory Healthcare
-
10.7.1 Emory Healthcare Company Profile and Recent Development
-
10.7.2 Market Performance
-
10.7.3 Product and Service Introduction
-
10.8 Biodesix
-
10.8.1 Biodesix Company Profile and Recent Development
-
10.8.2 Market Performance
-
10.8.3 Product and Service Introduction
-
10.9 Courtagen Life Sciences Inc
-
10.9.1 Courtagen Life Sciences Inc Company Profile and Recent Development
-
10.9.2 Market Performance
-
10.9.3 Product and Service Introduction
-
10.10 GlycoZym
-
10.10.1 GlycoZym Company Profile and Recent Development
-
10.10.2 Market Performance
-
10.10.3 Product and Service Introduction
-
10.11 Agilent
-
10.11.1 Agilent Company Profile and Recent Development
-
10.11.2 Market Performance
-
10.11.3 Product and Service Introduction
The List of Tables and Figures
-
Figure Product Picture
-
Figure USA Lung Cancer Diagnostic Tests Market Size and Growth Rate of Immunoassays from 2016 to 2027
-
Figure USA Lung Cancer Diagnostic Tests Market Size and Growth Rate of Flow Cytometry from 2016 to 2027
-
Figure USA Lung Cancer Diagnostic Tests Market Size and Growth Rate of Rapid Tests from 2016 to 2027
-
Figure USA Lung Cancer Diagnostic Tests Market Size and Growth Rate of Molecular Assays from 2016 to 2027
-
Figure USA Lung Cancer Diagnostic Tests Market Size and Growth Rate of Tissue Arrays from 2016 to 2027
-
Figure USA Lung Cancer Diagnostic Tests Market Size and Growth Rate of Circulating Tumor Cells from 2016 to 2027
-
Figure USA Lung Cancer Diagnostic Tests Market Size and Growth Rate of Pharmacodiagnostics from 2016 to 2027
-
Figure USA Lung Cancer Diagnostic Tests Market Size and Growth Rate of Biomarkers from 2016 to 2027
-
Figure USA Lung Cancer Diagnostic Tests Market Size and Growth Rate of Other Diagnostics Methods from 2016 to 2027
-
Figure Market Share by Type in 2016
-
Figure Market Share by Type in 2020
-
Figure Market Share by Type in 2027
-
Figure USA Lung Cancer Diagnostic Tests Market Size and Growth Rate of Precision Medicine from 2016 to 2027
-
Figure USA Lung Cancer Diagnostic Tests Market Size and Growth Rate of Personalized Medicine from 2016 to 2027
-
Figure USA Lung Cancer Diagnostic Tests Market Size and Growth Rate of Cancer Monitoring from 2016 to 2027
-
Figure Market Share by End-User in 2016
-
Figure Market Share by End-User in 2020
-
Figure Market Share by End-User in 2027
-
Figure West USA Lung Cancer Diagnostic Tests Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure South USA Lung Cancer Diagnostic Tests Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Middle West USA Lung Cancer Diagnostic Tests Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Northeast USA Lung Cancer Diagnostic Tests Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Development Trends and Industry Dynamics of Lung Cancer Diagnostic Tests Industry
-
Figure Market Challenges and Restraints
-
Figure Market Opportunities and Potentials
-
Table Mergers and Acquisition
-
Figure Market Share of TOP 3 Players in 2019
-
Figure Market Share of TOP 5 Players in 2019
-
Figure Market Share of TOP 6 Players from 2016 to 2020
-
Figure Porter's Five Forces Analysis
-
Figure New Entrant SWOT Analysis
-
Figure Coronavirus (COVID-19) Distribution Map of USA
-
Table Coronavirus (COVID-19) Impact on the Industry
-
Figure Specifications of Different Types of Lung Cancer Diagnostic Tests
-
Figure Development Trends of Different Types
-
Table Products Types of Major Vendors
-
Figure Competitive Landscape Analysis of Different Types
-
Table Consumption of Lung Cancer Diagnostic Tests by Different Types from 2016 to 2027
-
Table Consumption Share of Lung Cancer Diagnostic Tests by Different Types from 2016 to 2027
-
Figure Market Size and Growth Rate of Immunoassays
-
Figure Market Size and Growth Rate of Flow Cytometry
-
Figure Market Size and Growth Rate of Rapid Tests
-
Figure Market Size and Growth Rate of Molecular Assays
-
Figure Market Size and Growth Rate of Tissue Arrays
-
Figure Market Size and Growth Rate of Circulating Tumor Cells
-
Figure Market Size and Growth Rate of Pharmacodiagnostics
-
Figure Market Size and Growth Rate of Biomarkers
-
Figure Market Size and Growth Rate of Other Diagnostics Methods
-
Table Downstream Client Analysis by End-Users
-
Figure Competitive Landscape Analysis of Different End-Users
-
Table Market Potential Analysis of Different End-Users
-
Figure Consumption of Lung Cancer Diagnostic Tests by Different End-Users from 2016 to 2027
-
Table Consumption Share of Lung Cancer Diagnostic Tests by Different End-Users from 2016 to 2027
-
Figure Market Size and Growth Rate of Precision Medicine
-
Figure Market Size and Growth Rate of Personalized Medicine
-
Figure Market Size and Growth Rate of Cancer Monitoring
-
Table USA Lung Cancer Diagnostic Tests Production by Regions
-
Table USA Lung Cancer Diagnostic Tests Production Share by Regions
-
Figure USA Lung Cancer Diagnostic Tests Production Share by Regions in 2016
-
Figure USA Lung Cancer Diagnostic Tests Production Share by Regions in 2021
-
Figure USA Lung Cancer Diagnostic Tests Production Share by Regions in 2027
-
Table USA Lung Cancer Diagnostic Tests Consumption by Regions
-
Table USA Lung Cancer Diagnostic Tests Consumption Share by Regions
-
Figure USA Lung Cancer Diagnostic Tests Consumption Share by Regions in 2016
-
Figure USA Lung Cancer Diagnostic Tests Consumption Share by Regions in 2021
-
Figure USA Lung Cancer Diagnostic Tests Consumption Share by Regions in 2027
-
Table West USA Lung Cancer Diagnostic Tests Consumption by Types from 2016 to 2027
-
Table West USA Lung Cancer Diagnostic Tests Consumption Share by Types from 2016 to 2027
-
Figure West USA Lung Cancer Diagnostic Tests Consumption Share by Types in 2016
-
Figure West USA Lung Cancer Diagnostic Tests Consumption Share by Types in 2021
-
Figure West USA Lung Cancer Diagnostic Tests Consumption Share by Types in 2027
-
Table West USA Lung Cancer Diagnostic Tests Consumption by End-Users from 2016 to 2027
-
Table West USA Lung Cancer Diagnostic Tests Consumption Share by End-Users from 2016 to 2027
-
Figure West USA Lung Cancer Diagnostic Tests Consumption Share by End-Users in 2016
-
Figure West USA Lung Cancer Diagnostic Tests Consumption Share by End-Users in 2021
-
Figure West USA Lung Cancer Diagnostic Tests Consumption Share by End-Users in 2027
-
Table South USA Lung Cancer Diagnostic Tests Consumption by Types from 2016 to 2027
-
Table South USA Lung Cancer Diagnostic Tests Consumption Share by Types from 2016 to 2027
-
Figure South USA Lung Cancer Diagnostic Tests Consumption Share by Types in 2016
-
Figure South USA Lung Cancer Diagnostic Tests Consumption Share by Types in 2021
-
Figure South USA Lung Cancer Diagnostic Tests Consumption Share by Types in 2027
-
Table South USA Lung Cancer Diagnostic Tests Consumption by End-Users from 2016 to 2027
-
Table South USA Lung Cancer Diagnostic Tests Consumption Share by End-Users from 2016 to 2027
-
Figure South USA Lung Cancer Diagnostic Tests Consumption Share by End-Users in 2016
-
Figure South USA Lung Cancer Diagnostic Tests Consumption Share by End-Users in 2021
-
Figure South USA Lung Cancer Diagnostic Tests Consumption Share by End-Users in 2027
-
Table Middle West USA Lung Cancer Diagnostic Tests Consumption by Types from 2016 to 2027
-
Table Middle West USA Lung Cancer Diagnostic Tests Consumption Share by Types from 2016 to 2027
-
Figure Middle West USA Lung Cancer Diagnostic Tests Consumption Share by Types in 2016
-
Figure Middle West USA Lung Cancer Diagnostic Tests Consumption Share by Types in 2021
-
Figure Middle West USA Lung Cancer Diagnostic Tests Consumption Share by Types in 2027
-
Table Middle West USA Lung Cancer Diagnostic Tests Consumption by End-Users from 2016 to 2027
-
Table Middle West USA Lung Cancer Diagnostic Tests Consumption Share by End-Users from 2016 to 2027
-
Figure Middle West USA Lung Cancer Diagnostic Tests Consumption Share by End-Users in 2016
-
Figure Middle West USA Lung Cancer Diagnostic Tests Consumption Share by End-Users in 2021
-
Figure Middle West USA Lung Cancer Diagnostic Tests Consumption Share by End-Users in 2027
-
Table Northeast USA Lung Cancer Diagnostic Tests Consumption by Types from 2016 to 2027
-
Table Northeast USA Lung Cancer Diagnostic Tests Consumption Share by Types from 2016 to 2027
-
Figure Northeast USA Lung Cancer Diagnostic Tests Consumption Share by Types in 2016
-
Figure Northeast USA Lung Cancer Diagnostic Tests Consumption Share by Types in 2021
-
Figure Northeast USA Lung Cancer Diagnostic Tests Consumption Share by Types in 2027
-
Table Northeast USA Lung Cancer Diagnostic Tests Consumption by End-Users from 2016 to 2027
-
Table Northeast USA Lung Cancer Diagnostic Tests Consumption Share by End-Users from 2016 to 2027
-
Figure Northeast USA Lung Cancer Diagnostic Tests Consumption Share by End-Users in 2016
-
Figure Northeast USA Lung Cancer Diagnostic Tests Consumption Share by End-Users in 2021
-
Figure Northeast USA Lung Cancer Diagnostic Tests Consumption Share by End-Users in 2027
-
Table Company Profile and Development Status of Epigenomics AG
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Epigenomics AG
-
Figure Sales and Growth Rate Analysis of Epigenomics AG
-
Figure Revenue and Market Share Analysis of Epigenomics AG
-
Table Product and Service Introduction of Epigenomics AG
-
Table Company Profile and Development Status of BioMarker Strategies
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of BioMarker Strategies
-
Figure Sales and Growth Rate Analysis of BioMarker Strategies
-
Figure Revenue and Market Share Analysis of BioMarker Strategies
-
Table Product and Service Introduction of BioMarker Strategies
-
Table Company Profile and Development Status of Quest Diagnostics
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Quest Diagnostics
-
Figure Sales and Growth Rate Analysis of Quest Diagnostics
-
Figure Revenue and Market Share Analysis of Quest Diagnostics
-
Table Product and Service Introduction of Quest Diagnostics
-
Table Company Profile and Development Status of Mayo Clinic
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Mayo Clinic
-
Figure Sales and Growth Rate Analysis of Mayo Clinic
-
Figure Revenue and Market Share Analysis of Mayo Clinic
-
Table Product and Service Introduction of Mayo Clinic
-
Table Company Profile and Development Status of AIT
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of AIT
-
Figure Sales and Growth Rate Analysis of AIT
-
Figure Revenue and Market Share Analysis of AIT
-
Table Product and Service Introduction of AIT
-
Table Company Profile and Development Status of HalioDx
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of HalioDx
-
Figure Sales and Growth Rate Analysis of HalioDx
-
Figure Revenue and Market Share Analysis of HalioDx
-
Table Product and Service Introduction of HalioDx
-
Table Company Profile and Development Status of Emory Healthcare
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Emory Healthcare
-
Figure Sales and Growth Rate Analysis of Emory Healthcare
-
Figure Revenue and Market Share Analysis of Emory Healthcare
-
Table Product and Service Introduction of Emory Healthcare
-
Table Company Profile and Development Status of Biodesix
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Biodesix
-
Figure Sales and Growth Rate Analysis of Biodesix
-
Figure Revenue and Market Share Analysis of Biodesix
-
Table Product and Service Introduction of Biodesix
-
Table Company Profile and Development Status of Courtagen Life Sciences Inc
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Courtagen Life Sciences Inc
-
Figure Sales and Growth Rate Analysis of Courtagen Life Sciences Inc
-
Figure Revenue and Market Share Analysis of Courtagen Life Sciences Inc
-
Table Product and Service Introduction of Courtagen Life Sciences Inc
-
Table Company Profile and Development Status of GlycoZym
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of GlycoZym
-
Figure Sales and Growth Rate Analysis of GlycoZym
-
Figure Revenue and Market Share Analysis of GlycoZym
-
Table Product and Service Introduction of GlycoZym
-
Table Company Profile and Development Status of Agilent
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Agilent
-
Figure Sales and Growth Rate Analysis of Agilent
-
Figure Revenue and Market Share Analysis of Agilent
-
Table Product and Service Introduction of Agilent
-
